Drug Profile
Research programme: G protein-coupled receptor 119 agonists - Kalypsys
Alternative Names: GPR119Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Kalypsys
- Class
- Mechanism of Action G protein-coupled receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes - Diabetes mellitus
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Diabetes-mellitus in USA